The Trump administration seeks higher overseas drug prices as it plans to impose Most Favored Nation policy, which aims to ...

Lilly has been chasing—and gaining on—its chief metabolic medicine rival Novo Nordisk and its counterpart GLP-1s Ozempic and ...

Following a barrage of letters from President Donald Trump urging 17 large pharmaceutical companies to implement Most Favored ...

Black Book Research Survey Finds Trade Policy Shifts, MFN Enforcement, and Supply Chain Vulnerabilities Driving a High-Stakes ...

TAIPEI (Taiwan News) — The Office of Trade Negotiations confirmed Friday that Taiwan’s tariff on US imports is calculated by ...

The India-UK FTA is a strategic milestone for India’s husked or brown rice (HS code 100620), as it offers a significant edge ...

The Trump Administration is pursuing decidedly anti-growth policies. The results will be a weaker economy that violates his ...

German drugmaker Merck KGaA on Thursday joined peers in saying it was considering distribution models that serve U.S.

Even as it has been hit by a stinging 50% US tariff, India is skipping retaliation to opt for fast-track ...

From sweeping hikes to public barbs over Russian oil, the US  president’s latest policy barrage is reshaping India-US relations and redrawing the contours of global trade and strategic power ...

The Arizona congressional delegation should stand up for our bioscience sector and oppose any policy like Most Favored Nation ...

It’s a bad time to try to predict future pharmaceutical prices.